The statement addresses a public issue regarding pharmaceutical advertising policies in high-income countries, specifically the U.S. and New Zealand. It suggests a political action by advocating for the election of President Trump to address this issue, thus engaging in public discourse.
- The statement does not directly cause harm with words or actions, but it could be seen as promoting a political agenda without clear evidence of harm reduction.Principle 1:I will strive to do no harm with my words and actions.
- The statement does not engage in cyberbullying, harassment, or hate speech.Principle 2:I will respect the privacy and dignity of others and will not engage in cyberbullying, harassment, or hate speech.
- The statement does not actively promote understanding, empathy, or compassion, as it is more focused on political advocacy. [-1]Principle 3:I will use my words and actions to promote understanding, empathy, and compassion.
- The statement does not engage in constructive criticism or dialogue, as it does not provide a rationale for the proposed action or address potential counterarguments. [-1]Principle 4:I will engage in constructive criticism and dialogue with those in disagreement and will not engage in personal attacks or ad hominem arguments.
- The statement uses influence to advocate for a political outcome, but it does not clearly articulate how this would benefit society.Principle 6:I will use my influence for the betterment of society.
- The statement upholds free speech by expressing a political opinion, but it does not provide a responsible or well-reasoned argument for the proposed action.Principle 7:I will uphold the principles of free speech and use my platform responsibly and with integrity.